To validate the ability of this assay to detect ADAM8 expression in tissue samples, a set of tissue microarrays (TMAs) with 490 breast cancer biopsies, including 412 with data on expression of ER, PR and HER2 (including 61 TNBCs across the panel), were analyzed. This evidence concerns the gene ESR1 and breast carcinoma.